|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.986
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.949
|
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.919
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.884
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.872
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.861
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.853
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.838
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.824
|
Human |
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.819
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.780
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.767
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.659
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
8 |
0.653
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.634
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.619
|
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.596
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.596
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.572
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.570
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.538
|
|
|
|
postreplication repair
|
GO:0006301 |
5 |
0.524
|
|
|
|
non recombinational repair
|
GO:0000726 |
10 |
0.499
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.488
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.485
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.444
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.436
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.422
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.394
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.366
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.355
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.351
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.351
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.332
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.330
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.323
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.322
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.321
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.321
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.321
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.302
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.301
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.299
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.298
|
|
|
|
synapsis
|
GO:0007129 |
34 |
0.294
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.290
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.290
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.286
|
Human |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.281
|
|
|
|
dna catabolic process exonucleolytic
|
GO:0000738 |
3 |
0.278
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.277
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.276
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.265
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.263
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.262
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.261
|
Human |
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.258
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.257
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.246
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.242
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.238
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.232
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.229
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.228
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.215
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.209
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.209
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.208
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.204
|
Human |
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.198
|
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.197
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.195
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.194
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.191
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.189
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.186
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.182
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.181
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.180
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.180
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.175
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.171
|
Human |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.171
|
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.171
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.170
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.166
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.163
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.160
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.158
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.153
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.150
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.149
|
Human |
|
|
recombinational repair
|
GO:0000725 |
21 |
0.147
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.146
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.145
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.145
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.144
|
|
|
|
negative regulation of dna dependent dna replication
|
GO:2000104 |
1 |
0.143
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.136
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.132
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.130
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.128
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.128
|
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.127
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
21 |
0.126
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.126
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.122
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.122
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.119
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.116
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.116
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.112
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.110
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.110
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.109
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.109
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.108
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.107
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.107
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.107
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.106
|
|
|
|
base excision repair
|
GO:0006284 |
9 |
0.102
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.101
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.101
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.100
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.098
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.098
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.098
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.097
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.093
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.093
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.093
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.092
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.092
|
Human |
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.091
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.091
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.090
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.090
|
Human |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.090
|
Human |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.090
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.088
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.088
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.088
|
Human |
|
|
lipid localization
|
GO:0010876 |
126 |
0.088
|
|
|
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
9 |
0.088
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.087
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.086
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.086
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.084
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.083
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.083
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.082
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.082
|
|
|
|
regulation of dna endoreduplication
|
GO:0032875 |
3 |
0.082
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.080
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.080
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.079
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.079
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.078
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
8 |
0.078
|
|
|
|
regulation of dna replication
|
GO:0006275 |
17 |
0.077
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.076
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.076
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.076
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.075
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.075
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.074
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.074
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.072
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.072
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.072
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.071
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.071
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.071
|
Human |
|
|
protein processing
|
GO:0016485 |
163 |
0.070
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.070
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.070
|
Human |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.070
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.069
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.069
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.068
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.068
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.067
|
|
|
|
positive regulation of histone h3 k4 methylation
|
GO:0051571 |
5 |
0.067
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.067
|
|
|
|
regulation of protein autophosphorylation
|
GO:0031952 |
8 |
0.065
|
Human |
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.065
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.064
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.063
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.063
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.063
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.063
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.062
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.062
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.062
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.061
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.061
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.061
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.060
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.060
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.060
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.060
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.059
|
|
|
|
positive regulation of protein acetylation
|
GO:1901985 |
9 |
0.059
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.058
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.058
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.058
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.057
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.057
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.057
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.057
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.056
|
Human |
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.056
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.056
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.055
|
Human |
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.055
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.054
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.054
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.054
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.054
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.054
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.054
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.053
|
|
|
|
v d j recombination
|
GO:0033151 |
14 |
0.053
|
|
|
|
regulation of histone h4 acetylation
|
GO:0090239 |
3 |
0.053
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.052
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.052
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.051
|
Human |
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.051
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.051
|
|
|
|
regulation of metaphase anaphase transition of cell cycle
|
GO:1902099 |
9 |
0.051
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
18 |
0.051
|
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.050
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.050
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.049
|
Human |
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.049
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.049
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.049
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.048
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.048
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.048
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.048
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.047
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.047
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.046
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.046
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
19 |
0.046
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.046
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.045
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.045
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.044
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.044
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.044
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.044
|
Human |
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.044
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.043
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.042
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.042
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.042
|
|
|
|
histone mrna metabolic process
|
GO:0008334 |
3 |
0.042
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.042
|
Human |
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.041
|
|
|
|
chromosome separation
|
GO:0051304 |
14 |
0.041
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.041
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.041
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.041
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.041
|
Human |
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.040
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.040
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.039
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.039
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.039
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.039
|
|
|
|
positive regulation of histone acetylation
|
GO:0035066 |
8 |
0.039
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.038
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.038
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.037
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.037
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.037
|
|
|
|
phosphatidylinositol biosynthetic process
|
GO:0006661 |
15 |
0.037
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.037
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.037
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
27 |
0.037
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.037
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.036
|
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.036
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.036
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.036
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.036
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.036
|
|
|
|
replicative senescence
|
GO:0090399 |
2 |
0.035
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.035
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.035
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.035
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.035
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.035
|
Human |
|
|
regulation of sister chromatid segregation
|
GO:0033045 |
13 |
0.035
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.035
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
21 |
0.034
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.034
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.034
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.034
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.034
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.034
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.034
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.034
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.034
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.034
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.034
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.034
|
|
|
|
cohesin localization to chromatin
|
GO:0071921 |
1 |
0.033
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.033
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.032
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.032
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.032
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.031
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.031
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.031
|
|
|
|
negative regulation of fatty acid biosynthetic process
|
GO:0045717 |
7 |
0.031
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.031
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.031
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.031
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.030
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.030
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.030
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.030
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.030
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.030
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.030
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.030
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.030
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.030
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.030
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.030
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.030
|
|
|
|
mitotic cell cycle arrest
|
GO:0071850 |
4 |
0.029
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.029
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.029
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.028
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.028
|
|
|
|
negative regulation of nik nf kappab signaling
|
GO:1901223 |
2 |
0.028
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.028
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.028
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.028
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
Human |
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.027
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.027
|
|
|
|
cellular senescence
|
GO:0090398 |
11 |
0.027
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.027
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
13 |
0.027
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.027
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.027
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.027
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.027
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.027
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.027
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.026
|
|
|
|
centrosome cycle
|
GO:0007098 |
23 |
0.026
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
photoreceptor cell maintenance
|
GO:0045494 |
19 |
0.026
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.026
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.025
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.025
|
|
|
|
phosphatidylinositol 3 phosphate biosynthetic process
|
GO:0036092 |
6 |
0.025
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.025
|
|
|
|
regulation of microtubule polymerization
|
GO:0031113 |
7 |
0.025
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.025
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.025
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.024
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.024
|
|
|
|
attachment of spindle microtubules to kinetochore
|
GO:0008608 |
4 |
0.024
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.024
|
Human |
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.024
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.023
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.023
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.023
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.023
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.023
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.023
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.023
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.023
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.023
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.023
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.023
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.023
|
Human |
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.022
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.022
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.022
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.022
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.022
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.022
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.022
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.022
|
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.021
|
|
|
|
negative regulation of fibroblast migration
|
GO:0010764 |
2 |
0.021
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.021
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.021
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.021
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.021
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.021
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.021
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.021
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.021
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.020
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.020
|
|
|
|
negative regulation of cell cycle arrest
|
GO:0071157 |
1 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.020
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
15 |
0.020
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.020
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.020
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.020
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.020
|
|
|
|
translesion synthesis
|
GO:0019985 |
1 |
0.020
|
|
|
|
negative regulation of mammary gland epithelial cell proliferation
|
GO:0033600 |
3 |
0.020
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.019
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.019
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.019
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.019
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.019
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.019
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.019
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.019
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.018
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.018
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.018
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.018
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.018
|
Human |
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.018
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.018
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.018
|
|
|
|
positive regulation of peptidyl lysine acetylation
|
GO:2000758 |
9 |
0.018
|
|
|
|
anaphase promoting complex dependent proteasomal ubiquitin dependent protein catabolic process
|
GO:0031145 |
9 |
0.018
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.018
|
Human |
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.018
|
|
|
|
translation
|
GO:0006412 |
93 |
0.017
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.017
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.017
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.017
|
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
Human |
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.017
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.017
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.017
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.017
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.017
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.017
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.017
|
|
|
|
retina homeostasis
|
GO:0001895 |
23 |
0.017
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.017
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.017
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.017
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
22 |
0.017
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.017
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.017
|
Human |
|
|
centrosome duplication
|
GO:0051298 |
16 |
0.017
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.017
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.017
|
|